H2AX and cancer: Conversely, neither the PAR nor γ-H2AX protein was noted in the A549 NQO1-knockout cells after IP-DNQ treatment, indicating that IP-DNQ kills cancer cells in an NQO1-dependent manner (Figure 2D).